Pramipexole has moved up the in our algorithm for treatment resistant depression. Today, learn how to use this dopamine agonist.

New research moves pramipexole up in the algorithm for treatment resistant depression.

We interview Steve Hayes, originator of Acceptance and Commitment Therapy, on the personal struggles that inspired the treatment.

An interview with Steve Hayes, originator of Acceptance and Commitment Therapy (ACT), on how his struggle with panic disorder inspired his work.

A parent sits across from you and asks, "Why can't my child just take the same anxiety medicine that helps me?” Sounds reasonable, but the evidence tells a very different story.

How a new FDA approved device for difficult-to-treat depression engages the brain through the sensory nerves in part II of our interview with Linda Carpenter.

We interview Linda Carpenter, lead investigator on the new FDA approved device for difficult-to-treat depression.

Marsha Linehan finds the core principles of DBT in a Buddhist monastery, challenges the psychoanalytic establishment, and returns to the hospital where her journey started.